Pubblicazioni

Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience

2016 - THE BREAST

Moscetti, L; Vici, P; Gamucci, T; Natoli, C; Cortesi, Enrico; Marchetti, Paolo; Santini, D; Giuliani, R; Sperduti, I; Mauri, M; Pizzuti, Laura; Mancini, Ml; Fabbri, Maria Agnese; Magri, Valentina; Iezzi, L; Sini, Valentina; D'Onofrio, L; Mentuccia, Lucia; Vaccaro, A; Ramponi, S; Roma, Cl; Ruggeri, Em

Bevacizumab as first-line treatment in HER2-negative advanced breast cancer. Pros and cons

2016 - TUMORI

Sini, Valentina; Cassano, Alessandra; Corsi, Domenico; De Laurentiis, Michele; Gamucci, Teresa; Mauri, Mariella; Naso, Giuseppe; Roselli, Mario; Ruggeri, Enzo Maria; Tonini, Giuseppe; Vici, Patrizia; Zampa, Germano; Marchetti, Paolo

First-line therapy in HER2 positive metastatic breast cancer. Is the mosaic fully completed or are we missing additional pieces?

2016 - JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Fabi, A.; Malaguti, P.; Vari, S.; Cognetti, F.